Driven by rapid clinical translation, industrial-scale allogeneic production, and sustained public–private investment, the ...

The use of base editing to generate universal off-the-shelf CAR T cells induced durable remissions -- up to 36 months in one ...

Rising incidence rates, high recurrence, and limited curative options are accelerating demand for innovative glioblastoma ...

The combination of axi-cel and rituximab showed high efficacy in refractory LBCL, with a 73% complete response rate and 88% overall response rate. Safety was favorable, with no new signals; 96% ...

State public, charter and renaissance schools must come up with plans to restrict cell phone use in the 2026-27 school year, ...

Adani Solar has also been recognised as a Top Performer by Kiwa Photovoltaic Evolution Labs for the eighth consecutive year, ...

The Cellares Cell Shuttle platform was the first to receive the FDA’s Advanced Manufacturing Technology (AMT) designation, which offers partners additional touchpoints and priority review mechanisms ...

Jackery, a global leader in clean energy solutions, has been ranked No.1 globally by cumulative sales volume of 100-watt ...

The FDA approval of denileukin diftitox (Lymphir) marked a significant shift in this paradigm. As a first-in-class immunotoxin, it employs a dual-action mechanism: directly targeting interleukin-2 (IL ...

ElevateBio Life Edit (R) is the Company's gene editing technologies and R&D business, focused on building the world's largest gene editing toolbox to expand addressable diseases and open a new ...

Liu described the CAR-like T cells as cytokine-activated lymphocytes engineered with the tumor-targeting and -penetrating ...

Grade Purity, Third-Party Testing, and Mitochondrial Support Claims Are Reshaping Consumer Evaluation Standards for Methylene ...